
RGCC ONCONOMICS
RGCC Onconomics – Personalized Cancer Treatment Guidance
A comprehensive test that analyzes how your cancer cells respond to specific treatments, helping you make smarter therapy decisions
Onconomics is a personalized cancer profiling test developed by RGCC Group — a global leader in precision oncology. Using a sample of your blood, the test analyzes circulating tumor cells (CTCs) and evaluates which treatments (chemotherapy, targeted therapies, and natural substances) are most effective against your specific cancer profile.
This helps doctors avoid trial-and-error treatments and select options that are scientifically matched to your cancer’s behavior.

Benefits of RGCC Onconomics Test
Precision treatment matching for your unique cancer profile
Minimizes guesswork and unnecessary side effects
Includes both conventional drugs and natural compounds
Supports integrative oncology and personalized healing
Empowers patients and doctors to choose smarter, more targeted therapies
Can save time, cost, and emotional stress in the treatment journey
What to Expect
Blood draw performed by our doctor
Sample is sent to RGCC’s advanced lab in Europe
Results typically available in 2–3 weeks
Includes doctor consultation to explain results and support treatment planning